Gideon Capital Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-11,907
Closed -$214K 471
2018
Q2
$214K Sell
11,907
-16,074
-57% -$322K 0.11% 332
2018
Q1
$490K Buy
+27,981
New +$584K 0.3% 119
2017
Q3
Sell
-22,133
Closed -$447K 359
2017
Q2
$447K Buy
22,133
+10,168
+85% +$222K 0.49% 61
2017
Q1
$290K Sell
11,965
-3,367
-22% -$90.8K 0.17% 254
2016
Q4
$413K Buy
+15,332
New +$379K 0.26% 132

Other funds holding PTEN

Gideon Capital Advisors's PTEN Position: Q3 2018 in Review

Gideon Capital Advisors sold out of Patterson-UTI (PTEN) in Q3 2018, closing a stake of 11,907 shares — an estimated $214K sold.

Gideon Capital Advisors first reported a position in PTEN in Q4 2016 and held it in 5 quarters. The position peaked at $490K in Q1 2018. 307 funds tracked by Wall St. Rank hold PTEN as of Q3 2018.

  • Gideon Capital Advisors reported no remaining Patterson-UTI position as of Q3 2018 after selling out during the quarter.
  • Gideon Capital Advisors sold 11,907 Patterson-UTI shares in Q3 2018, an estimated $214K.
  • Gideon Capital Advisors first reported a position in Patterson-UTI in Q4 2016 and held it in 5 quarters.
  • Gideon Capital Advisors's Patterson-UTI position peaked at $490K in Q1 2018.
  • 307 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2018.

Based on Gideon Capital Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.